PROGRAM
2025 Satellite Symposia
Jul.24
LumiSTAR & Molecular Devices Session
Room 402C, Hall 1
Date / Time :July 24 13:00-17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 402C)
Jul.24
Treg Symposium 2025
Engineering Immune Peace: Translating Treg Science into Clinical Reality
Room 403, Hall 1
Date / Time : July 24 08:00-17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 403)
Co-organizer : Taiwan Bio Therapeutics INC.
| Time | Topic | Speaker |
|---|---|---|
| 08:00-08:30 | Registration | |
| 08:30-09:00 | Opening Remarks | Session Chair: Cyrus Yang |
| 09:00-10:00 | Discovery of New Immunotherapy Targets and Mechanisms Leveraging CRISPR | Arlene H. Sharpe Kolokotrones University Professor｜Harvard Medical School |
| 10:00-10:30 | Coffee Break | |
| 10:30-11:30 | Tfr Regulation of Antibody Mediated Diseases | Peter T. Sage Associate Professor of Medicine｜Harvard Medical School and Brigham and Women's Hospital |
| 11:30-13:00 | Lunch Break | |
| 13:00-14:00 | Therapy in Autoimmunity with a Focus on Inflammatory Bowel Disease | William A. Faubion Dean of Research, MCA｜Mayo Clinic Executive Medical Director, CRB｜Mayo Clinic |
| 14:00-15:00 | Polymeric Particles for Immunomodulation | Jordan J. Green Herschel L. Seder Professor of Biomedical Engineering｜Johns Hopkins University School of Medicine |
| 15:00-15:20 | Coffee Break | |
| 15:20-16:20 | Industry Perspective: Polyclonal Regulatory T Cell Therapy in Solid Organ Transplantation Clinical Trials |
Cyrus Yang |
| 16:20-17:00 | Panel Discussion & Concluding Remarks | Moderator: Cyrus Yang Panelists: Arlene H. Sharpe, Peter T. Sage, William A. Faubion, Jordan J. Green |
Regulatory T cells (Tregs) have long been recognized as central mediators of immune tolerance. What distinguishes the current moment in the field is the maturity of science and technology, which now makes it possible to translate decades of discovery into real therapeutic opportunities. With growing momentum in clinical trials and the advent of genetic engineering to enhance Treg stability, specificity, and function, Treg-based therapies are rapidly evolving from concept to clinic—offering new hope for patients with autoimmune diseases and for preventing transplant rejection.
Treg Symposium 2025 offers a timely and focused platform to explore these advances. By bringing together leading experts from both academia and industry, the symposium fosters the kind of interdisciplinary dialogue essential for addressing the scientific, clinical, and manufacturing challenges of Treg therapy. Topics will span from cutting-edge tools for understanding Treg biology and discovering new therapeutic opportunities, to clinical-stage developments of ex vivo Treg therapies and emerging strategies for in vivo Treg modulation.
Jul.24
Promega Session-Innovating Biologics: Accelerating Drug Discovery and Development with Functional Bioassays
Room 503, Hall 1
Date / Time : July 24 13:00–17:30
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 503)
Co-organizer : Promega Corporation
| Time | Topic | Speaker |
|---|---|---|
| 13:00-13:30 |
Registration |
|
| 13:30 |
Opening |
LayPing Lee |
| 13:35-14:20 |
Illuminating Biologics Drug Discovery with Innovative Assays |
Dr. Frank Fan |
| 14:20-15:20 |
The Bioluminescent Toolbox for Vaccine Characterization and mRNA Quality Control |
Dr. Jamison Grailer |
| 15:20-15:50 |
Promega Bioassays: Enabling Reliable Methodology for Research and Industrial Advancement |
Dr. Mei-Wei Lin |
| 15:50-16:00 |
Break |
|
| 16:00-16:30 |
Bioassays Development for Product Release and Characterization - From a CDMO Perspective |
Dr. Toby Hong |
| 16:30-17:20 |
Bioluminescent Platform Technologies for Functional Characterization of Advanced Cancer Therapeutics |
Dr. Jamison Grailer |
| 17:20 |
Closing |
Dr. Frank Fan |
Jul.25
AI for Bio-Pharma Integrated Practice of Design, Quality, and Manufacturing
Room 402AB, Hall 1
Date / Time : July 25 14:00-17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 402AB)
Co-organizer: Genetics Generation Advancement Corp, Taiwan Bio Industry Organization
| Time | Topic | Speaker |
|---|---|---|
| 14:00-14:30 |
Guest Registration |
|
| 14:30-14:45 |
Opening Remarks |
|
| 14:45-15:15 |
Session 1 –Harnessing AI to Decode Bio Signatures: A New Frontier in Precision Drug Development |
Tsai, Keng-Chang Professor Lucas Nivon |
| 15:15-15:45 |
Session 2 – Accelerating Drug Innovation and Lab Automation through AI |
Peng Hua |
| 15:45-15:50 |
Q&A |
|
| 15:50-16:10 |
Session 3 – Leveraging AI-Driven Process Optimization to Transform Biopharmaceutical Manufacturing
|
Jack Lim |
| 16:10-17:00 |
AI Demo Time |
|
Session Synopsis:
As the global AI era unfolds, artificial intelligence is rapidly transforming the biopharmaceutical landscape—from drug design and quality control to manufacturing processes. This forum, themed “AI for Bio-Pharma Integrated Practice of Design, Quality, and Manufacturing”, will spotlight the multifaceted applications and successful use cases of AI in the biopharmaceutical industry.
We are honored to bring together leading experts from both Taiwan and abroad, including representatives from the National Research Institute Of Chinese Medicine, Dassault Systèmes, and MasterControl. Together, they will explore how AI is becoming a critical driving force in the industry, unlocking new potential and future opportunities.
The forum will feature three key topics:
Harnessing AI to Decode Bio Signatures: A New Frontier in Precision Drug Development
Accelerating Drug Innovation and Lab Automation through AI: Enhancing pharmaceutical quality management and process innovation
Leveraging AI-Driven Process Optimization to Transform Biopharmaceutical Manufacturing: How electronic batch records are reshaping manufacturing and quality systems
On behalf of the Bionet Group, we sincerely invite professionals from pharmaceutical companies, biotech firms, CRDMOs, and academic research institutions to join us for this insightful event.
Jul.25
Breaking into the U.S. Healthcare Innovation Market
Room 404, Hall 1
Jul.25
Digital and Automated Cell Manufacturing: From QbD to AI and Robotics
Room 503, Hall 1
Date / Time : July 25 13:30–17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 503)
Co-organizer : Purple Win Co., Ltd.
| Time | Topic | Speaker |
|---|---|---|
| 13:30–14:00 |
Registration |
|
| 14:00–14:10 |
Opening Remarks |
Session Chair |
| 14:10–15:10 |
Advanced Morphological AI Analysis as a Process Analytical Technology for Quality by Design–Driven Process Development |
Ryuji Kato Associate Professor, Nagoya University, Tokai National Higher Education and Research System
|
| 15:10–15:30 |
Coffee Break |
|
| 15:30–15:40 |
2nd Opening Remark |
|
| 15:40–16:40 |
Development of robotic automation system for cell manufacturing |
Masahiro Kino-oka Professor, Department of Biotechnology, The University of Osaka
|
| 16:40–17:00 |
Closing Discussion |